R&D Days 2021

Welcome to the
Research and Development Days 2021


We are pleased to offer you the opportunity to join one of our virtual R&D events happening this year, to experience a scientific program, which showcases the Research and Development activities of Roche Diagnostics.

The events will take place on the following dates:
• 15 – 16 April NON ID*
• 10 – 11 June ID**
• 23 – 24 September NON ID
• 4 – 5 November ID

This is an ideal environment for healthcare professionals to learn about current and future innovations, as well as high-level scientific topics whilst having an opportunity to ask questions and knowledge exchange. The healthcare professionals receive detailed information on product performance, potential future developments and also hear an external physician's perspective on diagnostic solutions.


*NON ID: non-infectious diseases
**ID: infectious-diseases

R&D Days 2021


R&D Days
NON ID
The Non-ID R&D Days will focus on different topics in the disease areas Cardiovascular, Women’s health, Critical care, Neurology and Oncology. The participants will learn about the assay development from medical value assessment or the idea of a new assay to the development via clinical studies to launch and post launch activities of an IVD assay. The physician's perspective will give the participants insights into the newest diagnostic possibilities, challenges for diagnostics as well as the importance of diagnostics for patients and families.

R&D Days
ID
In the ID R&D Days the participants will learn about infectious diseases testing while going through some of the highlights from our SARS-CoV2 Assays development. The participants will learn about the assay development from medical value assessment or the idea of a new assay to the development via clinical studies to launch and post launch activities of an IVD assay. 

R&D Days
NON ID
The Non-ID R&D Days will focus on different topics in the disease areas Cardiovascular, Women’s health, Critical care, Neurology and Oncology. The participants will learn about the assay development from medical value assessment or the idea of a new assay to the development via clinical studies to launch and post launch activities of an IVD assay. The physician's perspective will give the participants insights into the newest diagnostic possibilities, challenges for diagnostics as well as the importance of diagnostics for patients and families.

R&D Days
ID
In the ID R&D Days the participants will learn about infectious diseases testing while going through some of the highlights from our SARS-CoV2 Assays development. The participants will learn about the assay development from medical value assessment or the idea of a new assay to the development via clinical studies to launch and post launch activities of an IVD assay. 

Meet the Speakers

Silke Luebcke
Daniel Cigoianu
Peter Kastner
Andreas Monsch
Sandra Rutz
Daniel Weinfurtner
Vinzent Rolny
Richard Tassoni
Stefan Zintzsch
Martin Klammer
Michael Hombach
Peter Muench
Thomas Mock
Michael Tacke
Ursula Giesen
Simon Jochum
LCT Project Lead - Roche Blood Safety Solutions (Serology), Roche Diagnostics, Penzberg, Germany
International Medical Manager – MSA CPS, Roche Diagnostics, Rotkreuz, Switzerland
Group Leader - Biomarker Discovery, Roche Diagnostics, Penzberg, Germany
Head of Memory Clinic, University Department of Geriatric Medicine FELIX Platter, Basel, Switzerland
Head of R&D, Personalized Healthcare Solutions (PHCS), Roche Diagnostics, Penzberg, Germany
Head of Protein Chemistry, Roche Diagnostics, Penzberg, Germany
Manager New Tech Statistics, Roche Diagnostics, Penzberg, Germany
Head of Standardization & QC SWA Cardiac WH, Roche Diagnostics, Penzberg, Germany
Manager Big Data Solutions @ cobas Cube, Roche Diagnostics, Penzberg, Germany
Senior Scientist Early Biomarker Development, Roche Diagnostics, Penzberg, Germany
Director, Senior Global Clinical Leader Infectious Diseases, Roche Diagnostics, Rotkreuz, Switzerland
Head R&D Assay Development, Infectious Diseases Concepts and Components, Roche Diagnostics, Penzberg, Germany
Manager Clon RM HBsAg, Hepato Viruses, Roche Diagnostics, Penzberg, Germany
Manager Biological Rare Reagents, Roche Diagnostics, Penzberg, Germany
Head of Case Investigation and Resolution HetIA ID & PMA Applications, Roche Diagnostics, Penzberg, Germany
Development Lead for Immunoassays on Infectious Diseases, Roche Diagnostics, Penzberg, Germany

Registration form

Please fill out the form to register for the event.